Th17 cells demonstrate stable cytokine production in a proallergic environment

Nicole L. Glosson-Byers, Sarita Sehra, Gretta L. Stritesky, Qing Yu, Olufolakemi Awe, Duy Pham, Heather A. Bruns, Mark H. Kaplan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Th17 cells are critical for the clearance of extracellular bacteria and fungi, but also contribute to the pathology of autoimmune diseases and allergic inflammation. After exposure to an appropriate cytokine environment, Th17 cells can acquire a Th1-like phenotype, but less is known about their ability to adopt Th2 and Th9 effector programs. To explore this in more detail, we used an IL-17F lineage tracer mouse strain that allows tracking of cells that formerly expressed IL-17F. In vitro-derived Th17 cells adopted signature cytokine and transcription factor expression when cultured under Th1-, Th2-, or Th9-polarizing conditions. In contrast, using two models of allergic airway disease, Th17 cells from the lungs of diseased mice did not adopt Th1, Th2, or Th9 effector programs, but remained stable IL-17 secretors. Although in vitro-derived Th17 cells expressed IL-4Ra, those induced in vivo during allergic airway disease did not, possibly rendering them unresponsive to IL-4-induced signals. However, in vitro- derived, Ag-specific Th17 cells transferred in vivo to OVA and aluminum hydroxide-sensitized mice also maintained IL-17 secretion and did not produce alternative cytokines upon subsequent OVA challenge. Thus, although Th17 cells can adopt new phenotypes in response to some inflammatory environments, our data suggest that in allergic inflammation, Th17 cells are comparatively stable and retain the potential to produce IL-17. This might reflect a cytokine environment that promotes Th17 stability, and allow a broader immune response at tissue barriers that are susceptible to allergic inflammation.

Original languageEnglish (US)
Pages (from-to)2631-2640
Number of pages10
JournalJournal of Immunology
Volume193
Issue number6
DOIs
StatePublished - Sep 15 2014

Fingerprint

Th17 Cells
Interleukin-17
Cytokines
Inflammation
Cell Tracking
Phenotype
Aluminum Hydroxide
Interleukin-4
Lung Diseases
Autoimmune Diseases
Fungi
Transcription Factors
Pathology
Bacteria

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Glosson-Byers, N. L., Sehra, S., Stritesky, G. L., Yu, Q., Awe, O., Pham, D., ... Kaplan, M. H. (2014). Th17 cells demonstrate stable cytokine production in a proallergic environment. Journal of Immunology, 193(6), 2631-2640. https://doi.org/10.4049/jimmunol.1401202

Th17 cells demonstrate stable cytokine production in a proallergic environment. / Glosson-Byers, Nicole L.; Sehra, Sarita; Stritesky, Gretta L.; Yu, Qing; Awe, Olufolakemi; Pham, Duy; Bruns, Heather A.; Kaplan, Mark H.

In: Journal of Immunology, Vol. 193, No. 6, 15.09.2014, p. 2631-2640.

Research output: Contribution to journalArticle

Glosson-Byers, NL, Sehra, S, Stritesky, GL, Yu, Q, Awe, O, Pham, D, Bruns, HA & Kaplan, MH 2014, 'Th17 cells demonstrate stable cytokine production in a proallergic environment', Journal of Immunology, vol. 193, no. 6, pp. 2631-2640. https://doi.org/10.4049/jimmunol.1401202
Glosson-Byers NL, Sehra S, Stritesky GL, Yu Q, Awe O, Pham D et al. Th17 cells demonstrate stable cytokine production in a proallergic environment. Journal of Immunology. 2014 Sep 15;193(6):2631-2640. https://doi.org/10.4049/jimmunol.1401202
Glosson-Byers, Nicole L. ; Sehra, Sarita ; Stritesky, Gretta L. ; Yu, Qing ; Awe, Olufolakemi ; Pham, Duy ; Bruns, Heather A. ; Kaplan, Mark H. / Th17 cells demonstrate stable cytokine production in a proallergic environment. In: Journal of Immunology. 2014 ; Vol. 193, No. 6. pp. 2631-2640.
@article{326ca8f3cfcd4574bbef77c53cdd0b4c,
title = "Th17 cells demonstrate stable cytokine production in a proallergic environment",
abstract = "Th17 cells are critical for the clearance of extracellular bacteria and fungi, but also contribute to the pathology of autoimmune diseases and allergic inflammation. After exposure to an appropriate cytokine environment, Th17 cells can acquire a Th1-like phenotype, but less is known about their ability to adopt Th2 and Th9 effector programs. To explore this in more detail, we used an IL-17F lineage tracer mouse strain that allows tracking of cells that formerly expressed IL-17F. In vitro-derived Th17 cells adopted signature cytokine and transcription factor expression when cultured under Th1-, Th2-, or Th9-polarizing conditions. In contrast, using two models of allergic airway disease, Th17 cells from the lungs of diseased mice did not adopt Th1, Th2, or Th9 effector programs, but remained stable IL-17 secretors. Although in vitro-derived Th17 cells expressed IL-4Ra, those induced in vivo during allergic airway disease did not, possibly rendering them unresponsive to IL-4-induced signals. However, in vitro- derived, Ag-specific Th17 cells transferred in vivo to OVA and aluminum hydroxide-sensitized mice also maintained IL-17 secretion and did not produce alternative cytokines upon subsequent OVA challenge. Thus, although Th17 cells can adopt new phenotypes in response to some inflammatory environments, our data suggest that in allergic inflammation, Th17 cells are comparatively stable and retain the potential to produce IL-17. This might reflect a cytokine environment that promotes Th17 stability, and allow a broader immune response at tissue barriers that are susceptible to allergic inflammation.",
author = "Glosson-Byers, {Nicole L.} and Sarita Sehra and Stritesky, {Gretta L.} and Qing Yu and Olufolakemi Awe and Duy Pham and Bruns, {Heather A.} and Kaplan, {Mark H.}",
year = "2014",
month = "9",
day = "15",
doi = "10.4049/jimmunol.1401202",
language = "English (US)",
volume = "193",
pages = "2631--2640",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "6",

}

TY - JOUR

T1 - Th17 cells demonstrate stable cytokine production in a proallergic environment

AU - Glosson-Byers, Nicole L.

AU - Sehra, Sarita

AU - Stritesky, Gretta L.

AU - Yu, Qing

AU - Awe, Olufolakemi

AU - Pham, Duy

AU - Bruns, Heather A.

AU - Kaplan, Mark H.

PY - 2014/9/15

Y1 - 2014/9/15

N2 - Th17 cells are critical for the clearance of extracellular bacteria and fungi, but also contribute to the pathology of autoimmune diseases and allergic inflammation. After exposure to an appropriate cytokine environment, Th17 cells can acquire a Th1-like phenotype, but less is known about their ability to adopt Th2 and Th9 effector programs. To explore this in more detail, we used an IL-17F lineage tracer mouse strain that allows tracking of cells that formerly expressed IL-17F. In vitro-derived Th17 cells adopted signature cytokine and transcription factor expression when cultured under Th1-, Th2-, or Th9-polarizing conditions. In contrast, using two models of allergic airway disease, Th17 cells from the lungs of diseased mice did not adopt Th1, Th2, or Th9 effector programs, but remained stable IL-17 secretors. Although in vitro-derived Th17 cells expressed IL-4Ra, those induced in vivo during allergic airway disease did not, possibly rendering them unresponsive to IL-4-induced signals. However, in vitro- derived, Ag-specific Th17 cells transferred in vivo to OVA and aluminum hydroxide-sensitized mice also maintained IL-17 secretion and did not produce alternative cytokines upon subsequent OVA challenge. Thus, although Th17 cells can adopt new phenotypes in response to some inflammatory environments, our data suggest that in allergic inflammation, Th17 cells are comparatively stable and retain the potential to produce IL-17. This might reflect a cytokine environment that promotes Th17 stability, and allow a broader immune response at tissue barriers that are susceptible to allergic inflammation.

AB - Th17 cells are critical for the clearance of extracellular bacteria and fungi, but also contribute to the pathology of autoimmune diseases and allergic inflammation. After exposure to an appropriate cytokine environment, Th17 cells can acquire a Th1-like phenotype, but less is known about their ability to adopt Th2 and Th9 effector programs. To explore this in more detail, we used an IL-17F lineage tracer mouse strain that allows tracking of cells that formerly expressed IL-17F. In vitro-derived Th17 cells adopted signature cytokine and transcription factor expression when cultured under Th1-, Th2-, or Th9-polarizing conditions. In contrast, using two models of allergic airway disease, Th17 cells from the lungs of diseased mice did not adopt Th1, Th2, or Th9 effector programs, but remained stable IL-17 secretors. Although in vitro-derived Th17 cells expressed IL-4Ra, those induced in vivo during allergic airway disease did not, possibly rendering them unresponsive to IL-4-induced signals. However, in vitro- derived, Ag-specific Th17 cells transferred in vivo to OVA and aluminum hydroxide-sensitized mice also maintained IL-17 secretion and did not produce alternative cytokines upon subsequent OVA challenge. Thus, although Th17 cells can adopt new phenotypes in response to some inflammatory environments, our data suggest that in allergic inflammation, Th17 cells are comparatively stable and retain the potential to produce IL-17. This might reflect a cytokine environment that promotes Th17 stability, and allow a broader immune response at tissue barriers that are susceptible to allergic inflammation.

UR - http://www.scopus.com/inward/record.url?scp=84907087908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907087908&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1401202

DO - 10.4049/jimmunol.1401202

M3 - Article

C2 - 25086171

AN - SCOPUS:84907087908

VL - 193

SP - 2631

EP - 2640

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 6

ER -